Alexandre Weinstein Manieu Acquires 452,702 Shares of Pluri (NASDAQ:PLUR) Stock

Pluri Inc. (NASDAQ:PLUR) Director Alexandre Weinstein Manieu bought 452,702 shares of the firm’s stock in a transaction that occurred on Monday, April 28th. The shares were purchased at an average cost of $4.61 per share, for a total transaction of $2,086,956.22. Following the purchase, the director owned 452,702 shares in the company, valued at $2,086,956.22. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Pluri Stock Up 10.9%

Shares of PLUR traded up $0.39 during mid-day trading on Thursday, hitting $3.96. 81,506 shares of the company’s stock were exchanged, compared to its average volume of 21,341. The stock’s 50-day moving average is $4.23 and its 200-day moving average is $4.69. The company has a debt-to-equity ratio of 51.65, a quick ratio of 0.68 and a current ratio of 0.68. Pluri Inc. has a fifty-two week low of $3.22 and a fifty-two week high of $7.13. The company has a market cap of $36.65 million, a price-to-earnings ratio of -0.77 and a beta of 0.63.

Pluri (NASDAQ:PLUR) last issued its quarterly earnings results on Wednesday, November 12th. The company reported ($0.65) EPS for the quarter. Pluri had a negative net margin of 1,701.19% and a negative return on equity of 4,191.91%. The business had revenue of $0.32 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Pluri in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, Pluri currently has an average rating of “Hold” and an average price target of $12.00.

Hedge Funds Weigh In On Pluri

An institutional investor recently bought a new position in Pluri stock. Jane Street Group LLC acquired a new stake in Pluri Inc. (NASDAQ:PLUR) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 10,928 shares of the company’s stock, valued at approximately $47,000. Jane Street Group LLC owned about 0.14% of Pluri at the end of the most recent quarter. 16.59% of the stock is owned by institutional investors and hedge funds.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.